716-1418

completed

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
716 (USA) · Dr. Ito
consented 2013-05-05

AEs

Serious

Dropout signal

–

Adverse events

mild assessed

Mild ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-05 (study day 1.0); relationship: PROBABLE

moderate assessed

Moderate HEADACHE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-07; relationship: POSSIBLE

moderate assessed

Moderate HEADACHE — outcome: RECOVERED/RESOLVED; onset 2013-07; relationship: POSSIBLE

mild assessed

Mild HEADACHE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-09-26 (study day 145.0); relationship: POSSIBLE

mild assessed

Mild HEADACHE — outcome: RECOVERED/RESOLVED; onset 2013-09-26 (study day 145.0); relationship: POSSIBLE

mild assessed

Mild PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-07 (study day 3.0); relationship: PROBABLE

mild assessed

Mild URTICARIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-05 (study day 1.0); relationship: PROBABLE

mild assessed

Mild URTICARIA — outcome: RECOVERED/RESOLVED; onset 2013-05-05 (study day 1.0); relationship: PROBABLE

moderate assessed

Moderate VISION BLURRED — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-07; relationship: POSSIBLE

moderate assessed

Moderate VISION BLURRED — outcome: RECOVERED/RESOLVED; onset 2013-07; relationship: POSSIBLE

Data queries

No data queries.